This is the authors' abstract. We don't add key points for this paper.
We describe an in vitro system that allows metacyclogenesis of T. brucei ssp. and is not restricted to certain parasite lines. Following the work of Hirumi and co-workers we developed a modified in vitro system which allows metacyclogenesis within 7 to 20 days. The most striking changes were the addition of citrate and cis-aconitate, which triggers transformation from bloodstream to procyclic forms, and the elimination of the remaining bloodstream forms by salicylhydroxamic acid and glycerol. A positive feature of this system is that T. b. gambiense samples isolated from patients, and transformed to procyclic forms for transport, could give rise to infective forms that could be passaged in rodents.
No takes yet. Share an insight, caveat, or question.
Nickel et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: